QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.107.041541v1 73/3/940    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wang, G. K. Articles by Wang, S.-Y. Search for Related Content PubMed PubMed Citation Articles by Wang, G. K. Articles by Wang, S.-Y.

State- and Use-Dependent Block of Muscle Nav1.4 and Neuronal Nav1.7 Voltage-Gated Na⁺ Channel Isoforms by Ranolazine

Department of Anesthesia, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts (G.K.W. and J.C.); and Department of Biology, State University of New York at Albany, Albany, New York (S.Y.W.).

Ranolazine is an antianginal agent that targets a number of ion channels in the heart, including cardiac voltage-gated Na⁺ channels. However, ranolazine block of muscle and neuronal Na⁺ channel isoforms has not been examined. We compared the state- and use-dependent ranolazine block of Na⁺ currents carried by muscle Nav1.4, cardiac Nav1.5, and neuronal Nav1.7 isoforms expressed in human embryonic kidney 293T cells. Resting and inactivated block of Na⁺ channels by ranolazine were generally weak, with a 50% inhibitory concentration (IC₅₀) 60 µM. Use-dependent block of Na⁺ channel isoforms by ranolazine during repetitive pulses (+50 mV/10 ms at 5 Hz) was strong at 100 µM, up to 77% peak current reduction for Nav1.4, 67% for Nav1.5, and 83% for Nav1.7. In addition, we found conspicuous time-dependent block of inactivation-deficient Nav1.4, Nav1.5, and Nav1.7 Na⁺ currents by ranolazine with estimated IC₅₀ values of 2.4, 6.2, and 1.7 µM, respectively. On- and off-rates of ranolazine were 8.2 µM^-1 s^-1 and 22 s^-1, respectively, for Nav1.4 open channels and 7.1 µM^-1 s^-1 and 14 s^-1, respectively, for Nav1.7 counterparts. A F1579K mutation at the local anesthetic receptor of inactivation-deficient Nav1.4 Na⁺ channels reduced the potency of ranolazine 17-fold. We conclude that: 1) both muscle and neuronal Na⁺ channels are as sensitive to ranolazine block as their cardiac counterparts; 2) at its therapeutic plasma concentrations, ranolazine interacts predominantly with the open but not resting or inactivated Na⁺ channels; and 3) ranolazine block of open Na⁺ channels is via the conserved local anesthetic receptor albeit with a relatively slow on-rate.

Address correspondence to: Ging Kuo Wang, Department of Anesthesia, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115. E-mail: wang{at}zeus.bwh.harvard.edu